Status:
COMPLETED
Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.
Lead Sponsor:
Lo.Li.Pharma s.r.l
Conditions:
Pregnancy, High Risk
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The trial aims to investigate the effect of supplementation with hyaluronic acid, alpha-lipoic acid, magnesium, vitamin D and vitamin B6 in progesterone-treated pregnant women with risk factors for ab...
Eligibility Criteria
Inclusion
- Women with risk factor for abortion (sub-chorionic hematoma during gestation or ART procedures)
Exclusion
- Other pregnancy-related conditions
- Diabetes or hypertension
- Concomitant pharmacological therapies (anticoagulant or antihypertensive)
- Use of tocolytic drugs two months prior to enrollment
- Association with hypoglycemic drugs
Key Trial Info
Start Date :
May 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 11 2023
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT04874285
Start Date
May 3 2021
End Date
May 11 2023
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Alma Res
Rome, Italy, 00198